ArticleMed (New York, N.Y.)2021

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.

Natalia Sherina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.